Feed
Search
Sign in
Company
ATNM
NYSE
New York, NY
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops radioconjugates for cancer treatment.
Stories only
SEC EDGAR
ClinicalTrials.gov
actiniumpharma.com
1
Story in coverage
0
Programs
0
Registered trials
424B3
Nov 6
Latest SEC filing
Oct 15
Latest story
Timeline
1
Pipeline
0
Trials
0
All
1
Filings and people
1
October 2026
Actinium names Matt David, M.D. as chief financial officer
Oct 15
People
Actinium Pharmaceuticals
Sign in